Pharmacological interactions with circling behaviour induced by the piperidinyl indole derivative RU 23686.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D002110:Caffeine / Q000494:pharmacology; D004347:Drug Interactions; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D007211:Indoles / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects
D007211:Indoles; D008781:Methyltyrosines; D018377:Neurotransmitter Agents; D010643:Phenoxybenzamine; D002110:Caffeine; C015625:RU 23686; D012110:Reserpine; D011433:Propranolol; D000661:Amphetamine; D012601:Scopolamine; D006220:Haloperidol; D001058:Apomorphine; D009526:Nialamide; D008784:Methysergide